There are 74 PCTs offering BTB. But does anyone know the financial value of these sales? The market has clearly not ascribed significant value to them since the share price has made no progress since August.
You say NICE will rubber stamp in February, but this is not certain. They could drag it out even longer if for whatever reason they don't reject STS's appeal out of hand. In any case NICE approval is now in the price.
Interim results in April will probably show no significant improvement in sales. Final results next September will probably be the first opportunity to show significant improvement.
The point about institutional support also still stands. I can't see the share price making any significant progress without it. So how are they going to attract institutional support?
Ultrasis stock quotes
Ultrasis stock charts
Follow this thread
